Legal Representation
Attorney
Jeffrey J. Ellison
USPTO Deadlines
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 2, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Nov 2, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Apr 3, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 1, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 1, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 1, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 1, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 6, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 6, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 17, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 21, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 21, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 29, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products for the treatment of systemic sclerosis, dermatomyositis, systemic lupus erythematosus, and cystic fibrosis
Classification
International Classes
005